Regeneron (REGN +2.5%) finishes the day higher, after its price target was raised to $175 from...

|About: Regeneron Pharmaceuticals, ... (REGN)|By:, SA News Editor

Regeneron (REGN +2.5%) finishes the day higher, after its price target was raised to $175 from $150 at RW Baird earlier today. The firm cites an upbeat survey for Eylea, and raises its estimates ahead of its Q3 results.